Roche Holding AG (OTCMKTS:RHHBY) Receives Average Recommendation of "Moderate Buy" from Brokerages

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, one has assigned a buy rating and two have given a strong buy rating to the company.

Several analysts recently weighed in on RHHBY shares. Hsbc Global Res cut shares of Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC lowered shares of Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th.

Roche Stock Performance

Shares of OTCMKTS:RHHBY opened at $40.16 on Tuesday. The firm's 50 day moving average price is $39.57 and its 200 day moving average price is $39.11. Roche has a fifty-two week low of $33.76 and a fifty-two week high of $44.31. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.

Institutional Investors Weigh In On Roche

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC lifted its holdings in Roche by 6,463.8% in the first quarter. GAMMA Investing LLC now owns 528,778 shares of the company's stock valued at $21,759,000 after acquiring an additional 520,722 shares during the period. Boston Common Asset Management LLC raised its stake in shares of Roche by 10.0% during the 1st quarter. Boston Common Asset Management LLC now owns 325,732 shares of the company's stock worth $13,369,000 after buying an additional 29,522 shares during the last quarter. Altrius Capital Management Inc raised its stake in shares of Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company's stock worth $7,818,000 after buying an additional 6,545 shares during the last quarter. Bard Financial Services Inc. raised its stake in shares of Roche by 25.3% during the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company's stock worth $5,716,000 after buying an additional 28,050 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in shares of Roche by 7.4% during the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company's stock worth $4,413,000 after buying an additional 7,374 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.